Abstract
The free extracellular concentrations of acyclovir and (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) in the blood and in brain tissue of rats were measured in microdialysis samples by high-pressure liquid chromatography with UV detection. The half-life of acyclovir in blood was 2 h, while that of H2G was 28 min. The concentration attained in the brain compared with the concentration in blood was slightly lower for H2G than for acyclovir. The results show that the pharmacokinetic profiles of acyclic nucleosides may vary as a consequence of the structure of the acyclic chain corresponding to the sugar moiety.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Laskin O. L. Clinical pharmacokinetics of acyclovir. Clin Pharmacokinet. 1983 May-Jun;8(3):187–201. doi: 10.2165/00003088-198308030-00001. [DOI] [PubMed] [Google Scholar]
- Saag M. S., Dismukes W. E. Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother. 1988 Jan;32(1):1–8. doi: 10.1128/aac.32.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ståhle L., Segersvärd S., Ungerstedt U. A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis. J Pharmacol Methods. 1991 Mar;25(1):41–52. doi: 10.1016/0160-5402(91)90021-v. [DOI] [PubMed] [Google Scholar]
- Ståhle L., Segersvärd S., Ungerstedt U. Drug distribution studies with microdialysis. II. Caffeine and theophylline in blood, brain and other tissues in rats. Life Sci. 1991;49(24):1843–1852. doi: 10.1016/0024-3205(91)90487-v. [DOI] [PubMed] [Google Scholar]
- Ståhle L., Segersvärd S., Ungerstedt U. Theophylline concentration in the extracellular space of the rat brain: measurement by microdialysis and relation to behaviour. Eur J Pharmacol. 1990 Aug 28;185(2-3):187–193. doi: 10.1016/0014-2999(90)90639-n. [DOI] [PubMed] [Google Scholar]
- de Miranda P., Krasny H. C., Page D. A., Elion G. B. The disposition of acyclovir in different species. J Pharmacol Exp Ther. 1981 Nov;219(2):309–315. [PubMed] [Google Scholar]